Director, Professor

Dr. Rohit S. Loomba, MD, is a board-certified gastroenterologist. His expertise includes treating and managing many types of chronic liver disease, such as nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis, chronic hepatitis, cirrhosis, and hemochromatosis. As a transplant hepatologist, Dr. Loomba works with transplant surgeons in the pre and postoperative care of liver transplant patients. He also directs the NAFLD Research Center at UC San Diego and leads a multidisciplinary group of investigators to study NAFLD.

Dr. Loomba believes in providing compassionate and state-of-the-art care to his patients. He also believes in the importance of strong physician-patient relationships for improving medical decision-making and delivering high-quality care in a friendly environment. As a professor in the Division of Gastroenterology, Dr. Loomba instructs students, residents, and fellows in the Department of Medicine at UC San Diego School of Medicine. His research focuses on all aspects of NAFLD, including prevalence in aging, epidemiology, genetic and environmental predisposition, and progression.

An advocate of evidence-based medicine, Dr. Loomba has led numerous clinical trials to help find innovative treatments for people suffering from liver illness. He also serves as the director of the Nonalcoholic Steatohepatitis (NASH) Clinical Research Network at UC San Diego. Sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases, the NASH Clinical Research Network aims to facilitate and perform clinical, epidemiological, and therapeutic research in nonalcoholic steatohepatitis.